Occupy the pit! Occupy the pit! Occupy the pit!

- Say the important thing three times!

——————————————————————

While speaking, Zhang Yinuo flipped through a folder in front of him, then took out a piece of information and handed it to Pei Pei and said: "Peer, take a look at this information, this is the market research report that has just been researched in the recent stage!" ”

Pei Pei nodded, then took the information and flipped it open

The research report shows that——

At present, all the patented products under the "Li Tang" brand add up, and there are only five fist products in total.

And these five fist products are only "partial" products for specific groups of people, and they only enjoy a certain degree of recognition and popularity among this specific consumer group.

Therefore, when it comes to the issue of share exchange, the senior executives present all know in their hearts - although the future potential of "Pell Biopharmaceutical Company" is endless, but only in terms of brand value and total asset value at this stage, it is not comparable to the listed Kangmei Group in any way.

Based on the current market value of the company, it is equivalent to about $30 million per share. If the share exchange plan with Kangmei Group is launched at this stage, one share will not be exchanged for 0.1 shares of the other party.

Therefore, the most urgent problem in front of everyone is to let the company's scientific research department develop more new products!

First, new products can be used to impact the current sluggish and sluggish market to solve the shrinkage phenomenon of continuous low performance;

Second, as long as each new patented product is successfully developed. It can make the total assets of Pell Company increase accordingly when it is evaluated, and it can not be "eaten shares" in the process of the formal implementation of the share exchange plan of the two companies!

Here we would like to mention the procedure for the exchange of shares of enterprises.

Because Pei Pei has watched the share exchange of Bank of America and Kangmei, she knows that under normal circumstances, before the share exchange, the two companies will entrust a professional asset appraisal company as a third party, and then the third-party professional appraisal company will make a reasonable share valuation of the total assets of the two companies.

——————————————————————

While speaking, Zhang Yinuo flipped through a folder in front of him, then took out a document and handed it to Pei Pei and said, "Pell." You can take a look at this information. This is a market research report that has just been researched in the recent stage! ”

Pei Pei nodded, then took the information and flipped it open

The research report shows that——

At present, all the patented products under the "Li Tang" brand add up, and there are only five fist products in total.

And these five fist products. It's just a "partial department" product for a specific group of people. It is only in this specific consumer group that enjoys a certain degree of recognition and popularity.

Therefore. When it comes to the issue of share exchange, the senior executives present all know in their hearts - although the future potential of "Pell Biopharma" is endless, but only in terms of brand value and total asset value at this stage. In any case, it is not as good as the listed Kangmei Group.

Based on the current market value of the company, it is equivalent to about $30 million per share. If the share exchange plan with Kangmei Group is launched at this stage, one share will not be exchanged for 0.1 shares of the other party.

Therefore, the most urgent problem in front of everyone is to let the company's scientific research department develop more new products!

First, new products can be used to impact the current sluggish and sluggish market to solve the shrinkage phenomenon of continuous low performance;

Second, as long as each new patented product is successfully developed, the total assets of Pell Company can be increased accordingly when it is evaluated, and it can not be "eaten shares" in the process of the official implementation of the share exchange plan of the two companies!

Here we would like to mention the procedure for the exchange of shares of enterprises.

Because Pei Pei has watched the share exchange of Bank of America and Kangmei, she knows that under normal circumstances, before the share exchange, the two companies will entrust a professional asset appraisal company as a third party, and then the third-party professional appraisal company will make a reasonable share valuation of the total assets of the two companies.

——————————————————————

While speaking, Zhang Yinuo flipped through a folder in front of him, then took out a piece of information and handed it to Pei Pei and said: "Peer, take a look at this information, this is the market research report that has just been researched in the recent stage!" ”

Pei Pei nodded, then took the information and flipped it open

The research report shows that——

At present, all the patented products under the "Li Tang" brand add up, and there are only five fist products in total.

And these five fist products are only "partial" products for specific groups of people, and they only enjoy a certain degree of recognition and popularity among this specific consumer group.

Therefore, when it comes to the issue of share exchange, the senior executives present all know in their hearts - although the future potential of "Pell Biopharmaceutical Company" is endless, but only in terms of brand value and total asset value at this stage, it is not comparable to the listed Kangmei Group in any way.

Based on the current market value of the company, it is equivalent to about $30 million per share. If the share exchange plan with Kangmei Group is launched at this stage, one share will not be exchanged for 0.1 shares of the other party.

Therefore, the most urgent problem in front of everyone is to let the company's scientific research department develop more new products!

First, new products can be used to impact the current sluggish and sluggish market to solve the shrinkage phenomenon of continuous low performance;

Second, as long as each new patented product is successfully developed, the total assets of Pell Company can be increased accordingly when it is evaluated, and it can not be "eaten shares" in the process of the official implementation of the share exchange plan of the two companies!

Here we would like to mention the procedure for the exchange of shares of enterprises.

Because Pei Pei has watched the share swap between Bank of America and Kangmei, she knows that usually, before the share swap, the two companies will entrust a professional asset appraisal company as a third party. Then, this third-party professional valuation firm makes a reasonable valuation of the total assets of the two companies.

——————————————————————

While speaking, Zhang Yinuo flipped through a folder in front of him, then took out a piece of information and handed it to Pei Pei and said: "Peer, take a look at this information, this is the market research report that has just been researched in the recent stage!" ”

Pei Pei nodded, then took the information and flipped it open

The research report shows that——

At present, all the patented products under the "Li Tang" brand add up, and there are only five fist products in total.

And these five fist products are only "partial" products for specific groups of people. It is only in this specific consumer group that enjoys a certain degree of recognition and popularity.

Therefore. When it comes to the issue of share exchange, the senior executives present all know in their hearts - although the future potential of "Pell Biopharmaceutical Company" is endless, but only in terms of brand value and total asset value at this stage, it is not comparable to the listed Kangmei Group in any way.

Calculated based on the current market capitalization of your company. That's about $30 million per share. If the share exchange plan with Kangmei Group is launched at this stage. One share cannot be exchanged for 0.1 shares of the other party.

So. The most urgent problem in front of everyone is to let the company's scientific research department develop more new products!

First, new products can be used to impact the current sluggish environment market. Addressing the shrinkage of declining performance;

Second, as long as each new patented product is successfully developed, the total assets of Pell Company can be increased accordingly when it is evaluated, and it can not be "eaten shares" in the process of the official implementation of the share exchange plan of the two companies!

Here we would like to mention the procedure for the exchange of shares of enterprises.

Because Pei Pei has watched the share exchange of Bank of America and Kangmei, she knows that under normal circumstances, before the share exchange, the two companies will entrust a professional asset appraisal company as a third party, and then the third-party professional appraisal company will make a reasonable share valuation of the total assets of the two companies.

——————————————————————

While speaking, Zhang Yinuo flipped through a folder in front of him, then took out a piece of information and handed it to Pei Pei and said: "Peer, take a look at this information, this is the market research report that has just been researched in the recent stage!" ”

Pei Pei nodded, then took the information and flipped it open

The research report shows that——

At present, all the patented products under the "Li Tang" brand add up, and there are only five fist products in total.

And these five fist products are only "partial" products for specific groups of people, and they only enjoy a certain degree of recognition and popularity among this specific consumer group.

Therefore, when it comes to the issue of share exchange, the senior executives present all know in their hearts - although the future potential of "Pell Biopharmaceutical Company" is endless, but only in terms of brand value and total asset value at this stage, it is not comparable to the listed Kangmei Group in any way.

Based on the current market value of the company, it is equivalent to about $30 million per share. If the share exchange plan with Kangmei Group is launched at this stage, one share will not be exchanged for 0.1 shares of the other party.

Therefore, the most urgent problem in front of everyone is to let the company's scientific research department develop more new products!

First, new products can be used to impact the current sluggish and sluggish market to solve the shrinkage phenomenon of continuous low performance;

Second, as long as each new patented product is successfully developed, the total assets of Pell Company can be increased accordingly when it is evaluated, and it can not be "eaten shares" in the process of the official implementation of the share exchange plan of the two companies!

Here we would like to mention the procedure for the exchange of shares of enterprises.

Because Pei Pei has watched the share exchange of Bank of America and Kangmei, she knows that under normal circumstances, before the share exchange, the two companies will entrust a professional asset appraisal company as a third party, and then the third-party professional appraisal company will make a reasonable share valuation of the total assets of the two companies.

————————————————————

While speaking, Zhang Yinuo flipped through a folder in front of him, then took out a piece of information and handed it to Pei Pei and said: "Peer, take a look at this information, this is the market research report that has just been researched in the recent stage!" ”

Pei Pei nodded, then took the information and flipped it open

The research report shows that——

At present, all the patented products under the "Li Tang" brand add up, and there are only five fist products in total.

And these five fist products are only "partial" products for specific groups of people, and they only enjoy a certain degree of recognition and popularity among this specific consumer group.

Therefore, when it comes to the issue of share exchange, the senior executives present all know in their hearts - although the future potential of "Pell Biopharmaceutical Company" is endless, but only in terms of brand value and total asset value at this stage, it is not comparable to the listed Kangmei Group in any way.

Based on the current market value of the company, it is equivalent to about $30 million per share. If the share exchange plan with Kangmei Group is launched at this stage, one share will not be exchanged for 0.1 shares of the other party.

Therefore, the most urgent problem in front of everyone is to let the company's scientific research department develop more new products!

First, new products can be used to impact the current sluggish and sluggish market to solve the shrinkage phenomenon of continuous low performance;

Second, as long as each new patented product is successfully developed, the total assets of Pell Company can be increased accordingly when it is evaluated, and it can not be "eaten shares" in the process of the official implementation of the share exchange plan of the two companies!

Here we would like to mention the procedure for the exchange of shares of enterprises.

Because Pei Pei has watched the share exchange of Bank of America and Kangmei, she knows that under normal circumstances, before the share exchange, the two companies will entrust a professional asset appraisal company as a third party, and then the third-party professional appraisal company will make a reasonable share valuation of the total assets of the two companies.

————————————————————

While speaking, Zhang Yinuo flipped through a folder in front of him, then took out a piece of information and handed it to Pei Pei and said: "Peer, take a look at this information, this is the market research report that has just been researched in the recent stage!" ”

Pei Pei nodded, then took the information and flipped it open

The research report shows that——

At present, all the patented products under the "Li Tang" brand add up, and there are only five fist products in total.

And these five fist products are only "partial" products for specific groups of people, and they only enjoy a certain degree of recognition and popularity among this specific consumer group. (To be continued.) )